About Chrono Therapeutics
Chrono Therapeutics is a company based in Waltham (United States) founded in 2004. It operates as a B2B. Chrono Therapeutics has raised $82.2 million across 8 funding rounds from investors including General Electric, HHS and Canaan. Chrono Therapeutics operates in a competitive market with competitors including Welldoc, DarioHealth, Wellthy Therapeutics, Valeritas and scPharmaceuticals, among others.
- Headquarter Waltham, United States
- SectorsHealthcare
- Website chronothera.com
- Social X
- Legal Name Chrono Therapeutics Inc.
- Total Equity Funding$82.2M (USD)
in 8 rounds
- InvestorsGeneral Electric
& 16 more
Funding Insights of Chrono Therapeutics
Chrono Therapeutics has successfully raised a total of $82.2M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $82.2M
- Total Rounds 8
- First Round $2.81M
(Sep 2012)
- Investors Count 17
All 8 funding rounds of Chrono Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2016 | – | Series B | – | Mayo Clinic Business Accelerator | – |
| Sep 2016 | $47.6M | Series B | – | Kaiser Permanente Ventures | |
| Aug 2015 | $2.3M | Grant | – | – | |
| Mar 2015 | $100,000 | Series A | – | – | |
| Jun 2014 | $34M | Series A | – | Canaan, 5AM Ventures | |
| Mar 2014 | $500,000 | Series A | – | – | – |
| Feb 2014 | $2.23M | Grant | – | – | |
| Sep 2012 | $2.81M | Grant | – | – |
17 investors in total: 17 institutional.
Investors in Chrono Therapeutics
Chrono Therapeutics has secured backing from 17 investors, including venture fund and institutional investors. Prominent investors backing the company include General Electric, HHS and Canaan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare startups are accelerated by Mayo Clinic Business Accelerator. | – | mcbusaccel.com | Rochester, United States | |
Tech and Life Sciences focused corporate VC firm investing in the US | – | kpventures.com | Oakland, United States | |
Endeavour Vision is focused on transformative healthcare technology investments. | – | endeavourvision.com | Geneva, Switzerland | |
Private equity investment firm | – | xeraya.com | Kuala Lumpur, Malaysia | |
Funding and expertise are provided for medical device development. | 2017 | emvllp.com | San Jose, United States | |
Canaan is recognized as an early-stage venture capital firm. | 1987 | canaan.com | San Francisco, United States | |
Venture capital fund backed incubator focused on the healthcare startups | – | 5amventures.com | San Francisco, United States | |
Risk capital is provided to life sciences entrepreneurs. | – | fh-partners.com | Dublin, Ireland | |
Hikma Ventures is focused on digital health investments. | 2015 | hikmaventures.com | London, United Kingdom | |
Stage-agnostic venture capital investments are focused on US sectors. | – | cotacapital.com | San Francisco, United States |
Investor details for Chrono Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Chrono Therapeutics
3 dated milestones of Chrono Therapeutics across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Chrono Therapeutics is founded.
- Funding First funding round of $2.8M.
- Funding Latest funding round, Series B,.
Competitors of Chrono Therapeutics
Chrono Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Welldoc, DarioHealth, Wellthy Therapeutics, Valeritas and scPharmaceuticals, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| welldoc.com | 2005 | Columbia, United States | $72.08M | 65 | Mobile health products for chronic disease management are offered. | |
| dariohealth.com | 2011 | New York, United States | $6.01M | 196 | Chronic conditions are managed via a personalized digital platform. | |
| wellthytherapeutics.com | 2015 | Mumbai, India | $8.91M | 25 | Health monitoring app is provided for chronic patients and providers. | |
| valeritas.com | 2003 | Bridgewater, United States | $181.36M | 141 | Wearable insulin patch pumps are developed for transdermal delivery. | |
| scpharmaceuticals.com | 2013 | Lexington, United States | $78.75M | 96 | Provider of a device for subcutaneous drug delivery for the treatment of bacterial infections and heart failure | |
| peartherapeutics.com | 2013 | Boston, United States | $266.34M | 207 | Pear Therapeutics provides cloud-based digital solutions for managing chronic health conditions effectively. | |
| crossject.com | 2001 | Dijon, France | $40.33M | – | Needle-free self-injectable drugs | |
| pivot.co | 2015 | San Carlos, United States | $43.3M | 60 | Digital health solutions for tobacco cessation are provided by Pivot. |
Detailed competitors of Chrono Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Chrono Therapeutics
The website of Chrono Therapeutics (chronothera.com) receives about 680.7K visits a month.
- Monthly visits680.7K
▼ 6.7% vs previous month
Websites whose visitors overlap most with Chrono Therapeutics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| falconebiz.com | 100% | 959.8K | #63,970 | View details | |
| tofler.in | 97% | 556K | #105,509 | View details | |
| zaubacorp.com | 96% | 4.9M | #12,689 | View details | |
| tracxn.com | 92% | 2.9M | #16,597 | View details | |
| indiafilings.com | 90% | 2.1M | #29,959 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Chrono Therapeutics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Chrono Therapeutics
Complete news archive for Chrono Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Chrono Therapeutics
10 companies that operate in the same segment as Chrono Therapeutics (Pain Management), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Developer of therapeutics for pain relief and inflammatory diseases | 2004 | New York, New York, United States | USD 51 M | USD 4.33 M | 79 | |
GPCR ligand-based therapeutics for cardiovascular diseases and pain are developed. | 2007 | Philadelphia, Pennsylvania, United States | USD 203 M | USD 3.13 M | 35 | |
Therapeutics for migraine treatment are developed using nasal delivery. | 2016 | San Francisco, California, United States | USD 74.13 M | – | 24 | |
Pain treatment products are developed through reformulation technologies. | 2007 | Herzliya, Central District, Israel | USD 12 M | USD 17 K | 6 | |
Drug delivery systems for CNS disorders and pain are developed. | 2006 | Emeryville, California, United States | USD 149.06 M | – | – | |
Developer of neuromodulation platform measuring biomarkers for chronic neurological condition treatment | 2010 | Bloomington, Indiana, United States | USD 530 M | USD 91.65 M | – | |
Therapies for pain and addiction treatment are developed. | 1977 | Saint-cloud, France | USD 248.09 M | USD 167.87 M | – | |
Novel drug products for chronic pain treatment are developed. | 2007 | Blue Bell, Pennsylvania, United States | USD 12.96 M | – | 17 | |
Abuse-deterrent extended-release therapeutics for chronic pain are developed. | 2002 | Canton, Ohio, United States | USD 103 M | USD 780.57 M | 357 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Chrono Therapeutics
Chrono Therapeutics was founded in 2004 and raised its 1st funding round 8 years after it was founded.
Chrono Therapeutics is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Chrono Therapeutics is a funded company, having raised a total of $82.2M across 8 funding rounds to date. The company's 1st funding round was a Grant of $2.81M, raised on Sep 2012.
Chrono Therapeutics, based in Waltham, focuses on providing healthcare solutions, developing medical devices, therapeutics, and smoking cessation. Develops transdermal nicotine replacement therapy for smoking cessation. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Chrono Therapeutics's top competitors include Welldoc, scPharmaceuticals and Wellthy Therapeutics.
Chrono Therapeutics has 17 investors. Key investors include General Electric, HHS, Canaan, National Cancer Institute, and Mayo Clinic Business Accelerator.
Chrono Therapeutics operates through Chrono Therapeutics Inc..
The website of Chrono Therapeutics receives about 681 thousand visits a month.